Exclusive: Nanobiomedicine

Application of nanotechnology in cancers prevention, diagnose and treatment

  • WANG Chao ,
  • FAN Qin ,
  • GU Zhen ,
  • LIU Zhuang
Expand
  • 1. Institute of Functional Nano & Soft Materials(FUNSOM), Suzhou 215123, China;
    2. Department of Bioengineering, University of California, Los Angeles 90095, USA

Received date: 2018-07-04

  Revised date: 2018-09-28

  Online published: 2018-12-14

Abstract

Cancer, as the one of the major diseases that threaten human health is an urgent challenge to be addressed. The design and application of functional nanomaterials and related systems for cancer treatment is an emerging research field, mainly associated with drug delivery systems, vaccine, diagnosis and imagining. To date, some of these outcomes could be seen in the clinical and preclinical studies, which provides the possibility for real-time monitoring, accurate evaluation and designation of personalized treatment. Here, we review the recent progress of utilizing nanotechnology in the field of cancer prevention, diagnosis, treatment, theranostics and clinical transformation. The prospects and challenges of this field are also discussed.

Cite this article

WANG Chao , FAN Qin , GU Zhen , LIU Zhuang . Application of nanotechnology in cancers prevention, diagnose and treatment[J]. Science & Technology Review, 2018 , 36(22) : 96 -107 . DOI: 10.3981/j.issn.1000-7857.2018.22.008

References

[1] Veiseh O, Kievit F M, Ellenbogen R G, et al. Cancer cell invasion:Treatment and monitoring opportunities in nanomedicine[J]. Advanced Drug Delivery Review, 2011, 63(8):582-596.
[2] Sun Q H, Zhou Z X, Qiu N S, et al. Rational design of cancer nanomedicine:Nanoproperty integration and synchronization[J]. Advanced Materials, 2017, 29(14):1606628.
[3] Gu X G, Kwok R T K, Lam J W Y, et al. Aiegens for biological process monitoring and disease theranostics[J]. Biomaterials, 2017, 146:115-135.
[4] Gu Z, Chen X Y. Towards enhancing skin drug delivery[J]. Advanced Drug Delivery Reviews, 2018, 127:1-2.
[5] Liu D, Yang F, Xiong F, et al. The smart drug delivery system and its clinical potential[J]. Theranostics, 2016, 6(9):1306-1323.
[6] Zhu G Z, Zhang F W, Ni Q Q, et al. Efficient nanovaccine delivery in cancer immunotherapy[J]. ACS Nano, 2017, 11(3):2387-2392.
[7] Guo Y, Wang D, Song Q, et al. Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma[J]. ACS Nano, 2015, 9(7):6918-6933.
[8] Chattopadhyay S, Dash S K, Mandal D, et al. Metal based nanoparticles as cancer antigen delivery vehicles for macrophage based antitumor vaccine[J]. Vaccine, 2016, 34(7):957-967.
[9] Shi G N, Zhang C N, Xu R, et al. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine[J]. Biomaterials, 2017, 113:191-202.
[10] Kuai R, Ochyl L J, Bahjat K S, et al. Designer vaccine nanodiscs for personalized cancer immunotherapy[J]. Nature Materials, 2016, 16:489.
[11] Luo M, Wang H, Wang Z H, et al. A STING-activating nanovaccine for cancer immunotherapy[J]. Nature Nanotechnology, 2017, 12(7):648-654.
[12] Zhao T, Huang G, Li Y, et al. A transistor-like pH nanoprobe for tumour detection and image-guided surgery[J]. Nature Biomedical Engineering, 2016, 1(1):6.
[13] Liu C H, Qi F P, Wen F B, et al. Fluorescence detection of glutathione (GSH) and oxidized glutathione (GSSG) in blood with a NIR-excitable cyanine probe[J]. Methods and Applications in Fluorescence, 2017, 25(4):580-586.
[14] Cui J B, Jiang R, Guo C, et al. Fluorine grafted Cu7S4-Au heterodimers for multimodal imaging guided photothermal therapy with high penetration depth[J]. Journal of the American Chemical Society, 2018, 140(18):5890-5894.
[15] Ye D Y, Shuhendler A J, Cui L N, et al. Bioorthogonal cyclizationmediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo[J]. Nature Chemistry, 2014, 6(6):519-526.
[16] Haun J B, Castro C M, Wang R, et al. Micro-NMR for rapid molecular analysis of human tumor samples[J]. Science Translational Medicine, 2011, 3(71):71ra16.
[17] Rizzi G, Lee J R, Dahl C, et al. Simultaneous profiling of DNA mutation and methylation by melting analysis using magnetoresistive biosensor array[J]. ACS Nano, 2017, 11(9):8864-8870.
[18] Zhao X, Guo B L, Wu H, et al. Injectable antibacterial conductive nanocomposite cryogels with rapid shape recovery for noncompressible hemorrhage and wound healing[J]. Nature Communications, 2018, 9(1):2784.
[19] Mahalingam S M, Kularatne S A, Myers C H, et al. Evaluation of novel tumor-targeted near-infrared probe for fluorescence-guided surgery of cancer[J]. Journal of Medicinal Chemistry, 2018, 61(21):9637-9646.
[20] Lu Y, Aimetti A A, Langer R, et al. Bioresponsive materials[J]. Nature Reviews Materials, 2016, 2:16075.
[21] Luo M, Feng Y Z, Wang T W, et al. Micro-/nanorobots at work in active drug delivery[J]. Advanced Functional Materials, 2018, 28(25):1706100.
[22] Ju C Y, Mo R, Xue J W, et al. Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration[J]. Angewandte Chemie International Edition, 2014, 53(24):6253-6258.
[23] Sivak L, Subr V, Tomala J, et al. Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate[J]. Biomaterials, 2017, 115:65-80.
[24] Fan K L, Jia X H, Zhou M, et al. Ferritin nanocarrier traverses the blood brain barrier and kills glioma[J]. ACS Nano, 2018, 12(5):4105-4115.
[25] Liang X L, Gao C, Cui L, et al. Self-assembly of an amphiphilic janus camptothecin-floxuridine conjugate into liposomelike nanocapsules for more efficacious combination chemotherapy in cancer[J]. Advanced Materials, 2017, 29(40):1703135.
[26] Lin T T, Zhao P F, Jiang Y F, et al. Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy[J]. ACS Nano, 2016, 10(11):9999-10012.
[27] Fan W P, Bu W B, Zhang Z, et al. X-ray radiation-controlled norelease for on-demand depth-independent hypoxic radiosensitization[J]. Angewandte Chemie International Edition, 2015, 54(47):14026-14030.
[28] Fan W P, Yung B, Huang P, et al. Nanotechnology for multimodal synergistic cancer therapy[J]. Chemical Reviews, 2017, 117(22):13566-13638.
[29] Song G S, Ji C H, Liang C, et al. TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy[J]. Biomaterials, 2017, 112:257-263.
[30] Du J, Gu Z, Yan L, et al. Poly(Vinylpyrollidone)-and selenocysteine-modified Bi2Se3 nanoparticles enhance radiotherapy efficacy in tumors and promote radioprotection in normal tissues[J]. Advanced Materials, 2017, 29(34):1701268.
[31] Yu C Y Y, Xu H, Ji S, et al. Mitochondrion-anchoring photosensitizer with aggregation-induced emission characteristics synergistically boosts the radiosensitivity of cancer cells to ionizing radiation[J]. Advanced Materials, 2017, 29(15):1606167.
[32] Yuan H X, Chong H, Wang B, et al. Chemical molecule-induced light-activated system for anticancer and antifungal activities[J]. Journal of the American Chemical Society, 2012, 134(32):13184-13187.
[33] Li A, Li X, Yu X J, et al. Synergistic thermoradiotherapy based on PEGylated Cu3BiS3 ternary semiconductor nanorods with strong absorption in the second near-infrared window[J]. Biomaterials, 2017, 112:164-175.
[34] Li R Y, Zhang L B, Shi L, et al. Mxene Ti3C2:An effective 2D light-to-heat conversion material[J]. ACS Nano, 2017, 11(4):3752-3759.
[35] Wang L, Gao C, Liu K Y, et al. Cypate-conjugated porous upconversion nanocomposites for programmed delivery of heat shock protein 70 small interfering RNA for gene silencing and photothermal ablation[J]. Advanced Functional Materials, 2016, 26(20):3480-3489.
[36] Yang Y, Zhu W J, Dong Z L, et al. 1D coordination polymer nanofibers for low-temperature photothermal therapy[J]. Advanced Materials, 2017, 29(40):1703588.
[37] Dong Q, Wang X W, Hu X X, et al. Simultaneous application of photothermal therapy and an anti-inflammatory prodrug using pyrene-aspirin-loaded gold nanorod graphitic nanocapsules[J]. Angewandte Chemie International Edition, 2017, 57(1):177-181.
[38] Chatterjee D K, Fong L S, Zhang Y. Nanoparticles in photodynamic therapy:An emerging paradigm[J]. Advanced Drug Delivery Reviews, 2008, 60(15):1627-1637.
[39] Idris N M, Gnanasammandhan M K, Zhang J, et al. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers[J]. Nature Medicine, 2012, 18(10):1580-1585.
[40] Xu J, Xu L G, Wang C Y, et al. Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer[J]. ACS Nano, 2017, 11(5):4463-4474.
[41] Wang C, Ye Y Q, Hu Q Y, et al. Tailoring biomaterials for cancer immunotherapy:Emerging trends and future outlook[J]. Advanced Materials, 2017, 29(29):1606036.
[42] Fan Q, Chen Z, Wang C, et al. Toward biomaterials for enhancing immune checkpoint blockade therapy[J]. Advanced Functional Materials, 2018, 28(37):1802540.
[43] Kelly S H, Shores L S, Votaw N L, et al. Biomaterial strategies for generating therapeutic immune responses[J]. Advanced Drug Delivery Reviews, 2017, 114:3-18.
[44] Wang C, Ye Y Q, Hochu G M, et al. Enhanced cancer immunotherapy by microneedle patch-assisted delivery of antiPD1 antibody[J]. Nano Letters, 2016, 16(4):2334-2340.
[45] Li A W, Sobral M C, Badrinath S, et al. A facile approach to enhance antigen response for personalized cancer vaccination[J]. Nature Materials, 2018, 17(6):528-534.
[46] Lizotte P H, Wen A M, Sheen M R, et al. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer[J]. Nature Nanotechnology, 2015, 11(3):295-303.
[47] Wang C, Wang J Q, Zhang X D, et al. In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy[J]. Science Translational Medicine, 2018, 10(429):eaan3682.
[48] Min Y Z, Roche K C, Tian S M, et al. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy[J]. Nature Nanotechnology, 2017, 12(9):877-882.
[49] Chao Y, Xu L G, Liang C, et al. Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses[J]. Nature Biomedical Engineering, 2018, 2(8):611-621.
[50] Lu K D, He C B, Guo N, et al. Low-dose X-ray radiotherapyradiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy[J]. Nature Biomedical Engineering, 2018:1-11.
[51] Zhu G Z, Mei L, Vishwasrao H D, et al. Intertwining DNARNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy[J]. Nature Communications, 2017, 8(1):1482.
[52] Huang J L, Jiang G, Song Q X, et al. Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis[J]. Nature Communications, 2017, 8:15144.
[53] Huang W, Chen L Q, Kang L, et al. Nanomedicine-based combination anticancer therapy between nucleic acids and smallmolecular drugs[J]. Advanced Drug Delivery Reviews, 2017, 115:82-97.
[54] Wang H X, Li M, Lee C M, et al. CRISPR/Cas9-based genome editing for disease modeling and therapy:Challenges and opportunities for nonviral delivery[J]. Chemical Reviews, 2017, 117(15):9874-9906.
[55] Wang P, Zhang L, Zheng W, et al. Thermo-triggered release of CRISPR-Cas9 system by lipid-encapsulated gold nanoparticles for tumor therapy[J]. Angewandte Chemie International Edition, 2018, 57(6):1491-1496.
[56] Dong Y C, Yang Y H, Zhang Y Y, et al. Cuboid vesicles formed by frame-guided assembly on DNA origami scaffolds[J]. Angewandte Chemie International Edition, 2017, 56(6):1586-1589.
[57] Ren K W, Liu Y, Wu J, et al. A DNA dual lock-and-key strategy for cell-subtype-specific siRNA delivery[J]. Nature Communications, 2016, 7:13580.
[58] Li S P, Jiang Q, Liu S L, et al. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo[J]. Nature Biotechnology, 2018, 36(3):258-264.
[59] Curley S A, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies:Results in 123 patients[J]. Annals of Surgery, 1999, 230(1):1.
[60] Rejinold N S, Jayakumar R, Kim Y C. Radio frequency responsive nano-biomaterials for cancer therapy[J]. Journal of Controlled Release, 2015, 204:85-97.
[61] Zhang K, Li P, Chen H R, et al. Continuous cavitation designed for enhancing radiofrequency ablation via a special radiofrequency solidoid vaporization process[J]. ACS Nano, 2016, 10(2):2549-2558.
[62] Jordan A, Scholz R, Wust P, et al. Magnetic fluid hyperthermia (MFH):Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles[J]. Journal of Magnetism and Magnetic Materials, 1999, 201(1):413-419.
[63] Kumar C S S R, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery[J]. Advanced Drug Delivery Reviews, 2011, 63(9):789-808.
[64] Liu X L, Yang Y, Ng C T, et al. Magnetic vortex nanorings:A new class of hyperthermia agent for highly efficient in vivo regression of tumors[J]. Advanced Materials, 2015, 27(11):1939-1944.
[65] Jang J T, Lee J, Seon J, et al. Giant magnetic heat induction of magnesium-doped γ-Fe2O3 superparamagnetic nanoparticles for completely killing tumors[J]. Advanced Materials, 2017, 30(6):1704362.
[66] Kennedy J E. High-intensity focused ultrasound in the treatment of solid tumours[J]. Nature Reviews Cancer, 2005, 5:321.
[67] Chen Y, Chen H R, Shi J L. Nanobiotechnology promotes noninvasive high-intensity focused ultrasound cancer surgery[J]. Advanced Healthcare Materials, 2014, 4(1):158-165.
[68] Wang X, Chen H R, Chen Y, et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU)[J]. Advanced Materials, 2012, 24(6):785-791.
[69] He S S, Li C, Zhang Q F, et al. Tailoring platinum(IV) amphiphiles for self-targeting all-in-one assemblies as precise multimodal theranostic nanomedicine[J]. ACS Nano, 2018, 12(7):7272-7281.
[70] Wei Q L, Chen Y, Ma X B, et al. High-efficient clearable nanoparticles for multi-modal imaging and image-guided cancer therapy[J]. Advanced Functional Materials, 2018, 28(2):1704634.
[71] Lin J, Wang M, Hu H, et al. Multimodal-imaging-guided cancer phototherapy by versatile biomimetic theranostics with UV and γ-irradiation protection[J]. Advanced Materials, 2016, 28(17):3273-3279.
[72] Chen Y Y, Cheng L, Dong Z L, et al. Degradable vanadium disulfide nanostructures with unique optical and magnetic functions for cancer theranostics[J]. Angewandte Chemie, 2017, 129(42):13171-13176.
[73] Yang G B, Xu L G, Chao Y, et al. Hollow MnO2 as a tumormicro environment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses[J]. Nature Communications, 2017, 8(1):902.
[74] Min Y, Caster J M, Eblan M J, et al. Clinical translation of nanomedicine[J]. Chemical Reviews, 2015, 115(19):11147-11190.
[75] Von Roemeling C, Jiang W, Chan C K, et al. Breaking down the barriers to precision cancer nanomedicine[J]. Trends in Biotechnology, 2017, 35(2):159-171.
[76] Nel A, Ruoslahti E, Meng H. New insights into "permeability" as in the enhanced permeability and retention effect of cancer nanotherapeutics[J]. ACS Nano, 2017, 11(10):9567-9569.
[77] Pelaz B, Alexiou C, Alvarez-Puebla R A, et al. Diverse applications of nanomedicine[J]. ACS Nano, 2017, 11(3):2313-2381.
Outlines

/